Patients in the < 131 mg/dL group were older and mostly males, with a higher prevalence of hypertension; previous percutaneous coronary interventions/coronary artery bypass grafts; and also, higher prevalence of receiving beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, and aspirin. This evidence concerns the gene ACE and Hypertension.